谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Immunogenicity and Safety of a SARS-CoV-2 Mrna Vaccine (SYS6006) in Healthy Chinese Participants: A Randomized, Observer-Blinded, Placebo-Controlled Phase 2 Clinical Trial.

Fei Jin,Yuanzheng Qiu,Zhiwei Wu,Yuan-Hui Wang,Chengye Cai, Liangcai Fu,Wenbin Jiao, Huixian Wang, Ming Gao,Chang Su,Jun-Heng Ma,Yan Xu,Chao-Chao Huang, Qing Zhang, Shaonan Ni, Maosheng Zhao, Lixian Guo, Li Ji,Hanyu Yang,Yuliang Zhao,Chunlei Li,Xiang Lu,Yu-Wen Su,Qi Li

VACCINE（2024）

引用 1|浏览21
关键词
SARS-CoV-2,mRNA vaccine,Safety,Immunogenicity,Phase 2 clinical trial
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要